Susan L. Binford

1.6k total citations
15 papers, 1.1k citations indexed

About

Susan L. Binford is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Susan L. Binford has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Susan L. Binford's work include Viral Infections and Immunology Research (10 papers), Respiratory viral infections research (7 papers) and RNA and protein synthesis mechanisms (5 papers). Susan L. Binford is often cited by papers focused on Viral Infections and Immunology Research (10 papers), Respiratory viral infections research (7 papers) and RNA and protein synthesis mechanisms (5 papers). Susan L. Binford collaborates with scholars based in United States and Japan. Susan L. Binford's co-authors include Amy K. Patick, David A. Matthews, James W. Meador, Shella A. Fuhrman, L S Zalman, M. A. Brothers, Fausto Maldonado, Stephen T. Worland, Rose Ann Ferre and Edward L. Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Susan L. Binford

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan L. Binford United States 12 528 420 408 303 183 15 1.1k
James W. Meador United States 16 563 1.1× 622 1.5× 435 1.1× 274 0.9× 241 1.3× 31 1.4k
Edward L. Brown United States 9 319 0.6× 332 0.8× 252 0.6× 139 0.5× 202 1.1× 10 754
Shella A. Fuhrman United States 23 623 1.2× 1.2k 2.8× 581 1.4× 418 1.4× 284 1.6× 32 2.2k
M. A. Brothers United States 9 378 0.7× 327 0.8× 259 0.6× 332 1.1× 62 0.3× 12 1.0k
Guy D. Diana United States 18 855 1.6× 472 1.1× 391 1.0× 508 1.7× 376 2.1× 39 1.6k
Yuri Kusov Germany 24 570 1.1× 760 1.8× 1.2k 3.0× 220 0.7× 152 0.8× 39 2.1k
Wade Blair United States 26 189 0.4× 664 1.6× 1.1k 2.6× 458 1.5× 146 0.8× 45 2.1k
Jérôme Deval United States 27 213 0.4× 510 1.2× 1.3k 3.2× 628 2.1× 131 0.7× 46 2.0k
Inge Vliegen Belgium 19 220 0.4× 341 0.8× 278 0.7× 592 2.0× 251 1.4× 33 1.4k
Clifford E. Ford United States 8 203 0.4× 195 0.5× 156 0.4× 115 0.4× 143 0.8× 8 486

Countries citing papers authored by Susan L. Binford

Since Specialization
Citations

This map shows the geographic impact of Susan L. Binford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Binford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Binford more than expected).

Fields of papers citing papers by Susan L. Binford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Binford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Binford. The network helps show where Susan L. Binford may publish in the future.

Co-authorship network of co-authors of Susan L. Binford

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Binford. A scholar is included among the top collaborators of Susan L. Binford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Binford. Susan L. Binford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shi, Stephanie T., Jim Nonomiya, Sadayappan V. Rahavendran, et al.. (2009). Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Antimicrobial Agents and Chemotherapy. 53(6). 2544–2552. 58 indexed citations
2.
Binford, Susan L., et al.. (2007). In Vitro Resistance Study of Rupintrivir, a Novel Inhibitor of Human Rhinovirus 3C Protease. Antimicrobial Agents and Chemotherapy. 51(12). 4366–4373. 53 indexed citations
3.
4.
Patick, Amy K., Mary A. Brothers, Fausto Maldonado, et al.. (2005). In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease. Antimicrobial Agents and Chemotherapy. 49(6). 2267–2275. 103 indexed citations
5.
Binford, Susan L., Fausto Maldonado, M. A. Brothers, et al.. (2005). Conservation of Amino Acids in Human Rhinovirus 3C Protease Correlates with Broad-Spectrum Antiviral Activity of Rupintrivir, a Novel Human Rhinovirus 3C Protease Inhibitor. Antimicrobial Agents and Chemotherapy. 49(2). 619–626. 121 indexed citations
6.
Reich, Siegfried, Theodore Johnson, Michael B. Wallace, et al.. (2000). Substituted Benzamide Inhibitors of Human Rhinovirus 3C Protease:  Structure-Based Design, Synthesis, and Biological Evaluation. Journal of Medicinal Chemistry. 43(9). 1670–1683. 40 indexed citations
7.
Dragovich, Peter S., Ru Zhou, Stephen E. Webber, et al.. (2000). Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(1). 45–48. 32 indexed citations
8.
Matthews, David A., Peter S. Dragovich, S. E. Webber, et al.. (1999). Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proceedings of the National Academy of Sciences. 96(20). 11000–11007. 243 indexed citations
9.
Dragovich, Peter S., Stephen E. Webber, Thomas J. Prins, et al.. (1999). Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids. Bioorganic & Medicinal Chemistry Letters. 9(15). 2189–2194. 18 indexed citations
10.
Patick, Amy K., Susan L. Binford, M. A. Brothers, et al.. (1999). In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease. Antimicrobial Agents and Chemotherapy. 43(10). 2444–2450. 175 indexed citations
11.
Webber, Stephen E., Kōji Okano, Thomas L. Little, et al.. (1998). Tripeptide Aldehyde Inhibitors of Human Rhinovirus 3C Protease:  Design, Synthesis, Biological Evaluation, and Cocrystal Structure Solution of P1 Glutamine Isosteric Replacements. Journal of Medicinal Chemistry. 41(15). 2786–2805. 73 indexed citations
12.
Binford, Susan L., et al.. (1997). Comparison of human cytomegalovirus (HCMV) protease sequences among laboratory strains and seven clinical isolates. Antiviral Research. 33(3). 215–218. 4 indexed citations
13.
Patick, Amy K., Susan L. Binford, Shella A. Fuhrman, et al.. (1997). Evaluation of the antiviral activity and cytotoxicity of peptidic inhibitors of human rhinovirus 3C protease, a novel target for antiviral intervention. Antiviral Research. 34(2). A75–A75. 6 indexed citations
14.
Ford, C. E., Susan L. Binford, Shella A. Fuhrman, et al.. (1997). Rhinovirus 3C protease inhibitors are efficacious against several related picornaviruses. Antiviral Research. 34(2). A90–A90. 1 indexed citations
15.
Webber, Stephen E., Jayashree Tikhe, Stephen T. Worland, et al.. (1996). Design, Synthesis, and Evaluation of Nonpeptidic Inhibitors of Human Rhinovirus 3C Protease. Journal of Medicinal Chemistry. 39(26). 5072–5082. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James W. Meador Breakdown of academic impact, for papers by Edward L. Brown Breakdown of academic impact, for papers by Shella A. Fuhrman Breakdown of academic impact, for papers by M. A. Brothers Breakdown of academic impact, for papers by Guy D. Diana Breakdown of academic impact, for papers by Yuri Kusov Breakdown of academic impact, for papers by Wade Blair Breakdown of academic impact, for papers by Jérôme Deval Breakdown of academic impact, for papers by Inge Vliegen Breakdown of academic impact, for papers by Clifford E. Ford
Rankless by CCL
2026